Growth, Tolerance, and Functional Biomarkers in Healthy Infants Receiving Dietary Supplements | MicrobiomeTrials← Back to trialsNCT07630584
Growth, Tolerance, and Functional Biomarkers in Healthy Infants Receiving Dietary Supplements
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-06-01Est. Completion: 2027-01-31
Enrollment target: 327 participants Other microbiome trials you might be interested in
Healthy
BEATRIX (group B strEptococcus mATeRnal and Infant VaX study) The purpose of this study is to learn about the safety and…
Birmingham, United StatesEst. completion Nov 6, 2028
Malaria
Background:
Malaria is a disease that affects many people in Africa. It is caused by germs carried by some mosquitoes. …
Ou(SqrRoot)(Copyright)less(SqrRoot)(Copyright)bougou, MaliCompleted Nov 30, 2026
Although most children with leukaemia are cured using drugs (chemotherapy) alone, for some children additional treatment…
Manchester, United KingdomEst. completion Jun 30, 2026